# Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

> **NCT07592481** · NA · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier de la côte Basque** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia (CLL)
- Follicular Lymphoma ( FL)
- Waldenstrom Macroglobulinaemia
- Lymphoplasmacytic Lymphoma
- Marginal Zone B Cell Lymphoma
- Mantle Cell Lymphoma

## Interventions

- **DEVICE:** Connected home blood pressure monitoring with daily IPA supervision.

## Key facts

- **NCT ID:** NCT07592481
- **Lead sponsor:** Centre Hospitalier de la côte Basque
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-18
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592481, "Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07592481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*